BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Catalyst Pharmaceuticals (CPRX) Announces Oral Presentation Of Firdapse Phase 3 Trial Data At American Academy of Neurology Annual Meeting 4/15/2015 3:09:16 PM
Catalyst Pharmaceuticals (CPRX) Announces Oral Presentation Of Firdapse Phase 3 Trial Data At American Academy of Neurology Annual Meeting (AAN) 4/14/2015 10:51:43 AM
Catalyst Pharmaceuticals (CPRX) Announces Fourth Quarter And Year-End 2014 Financial Results 3/16/2015 7:55:10 AM
Catalyst Pharmaceuticals (CPRX) To Present At The 27th Annual ROTH Conference 3/9/2015 8:09:01 AM
Catalyst Pharmaceuticals (CPRX) Announces FDA Orphan Drug Designation Of Firdapse For Treatment Of Congenital Myasthenic Syndromes 3/5/2015 9:30:06 AM
Catalyst Pharmaceuticals (CPRX) Announces Appointment Of Richard J. Daly And Donald A. Denkhaus To Its Board Of Directors 2/19/2015 12:49:18 PM
Catalyst Pharmaceuticals (CPRX) Announces Closing Of Previously Announced Public Offering 2/9/2015 10:37:00 AM
Catalyst Pharmaceuticals (CPRX) Prices Public Offering Of Common Stock 2/4/2015 7:43:57 AM
Catalyst Pharmaceuticals (CPRX) Announces Commencement Of Public Offering Of Common Stock 2/4/2015 7:42:50 AM
Catalyst Pharmaceuticals (CPRX) Announces Encouraging Pre-NDA Meeting With The FDA For Firdapse™ As A Treatment For Lambert-Eaton Myasthenic Syndrome (LEMS) 2/2/2015 8:08:29 AM
12345678910...